Calf Pain: Causes & Differential Diagnosis

🔴 Vascular (Urgent/Emergency)

🟠 Musculoskeletal

🟡 Compartment Syndrome

🟢 Neurological

🔵 Venous / Lymphatic

⚪ Other / Systemic

Red Flags Requiring Urgent Evaluation

• Unilateral calf swelling + pain → rule out DVT
• Sudden onset severe pain, absent pulse, pallor → acute limb ischemia
• Tense, woody compartment after trauma → acute compartment syndrome
• Pain at rest + ulceration/gangrene → critical limb ischemia
• Neurological deficits (weakness, reflex loss) → nerve root compression

• HR: ~60 bpm
• PR: ~00 ms (unclear)
• QRS: 112 ms
• QT/QTc: 615/1040 ms (these values appear very prolonged — likely a machine artifact/error)
• P AXIS: ~17°
• F AXIS: ~35°
• T AXIS: ~18°
• Remarks: "No Further Analysis" / "Mixed Pattern" — machine flagged this

ECG Interpretation

Rate & Rhythm

• Heart rate: ~60 bpm
• Rhythm: Regular sinus rhythm — P waves visible and consistent before each QRS

Axis

• P axis ~17° — normal
• QRS axis ~35° — normal axis

Intervals

• PR interval: Appears normal (~160–180 ms)
• QRS duration: 112 ms — borderline prolonged (≥120 ms = bundle branch block; 110–119 ms = incomplete BBB)

QRS Morphology — Key Finding

• V1: rSR' pattern (small r, deep S, terminal R') — rabbit ears morphology
• V4–V6: Broad, slurred S waves
• Lead I, aVL: Broad S waves

• rSR' ("M" shape) in V1
• Wide S waves in lateral leads (I, aVL, V5–V6)
• QRS ~112 ms (incomplete RBBB if <120 ms; complete if ≥120 ms — borderline here)

ST / T Waves

• In V1–V3: ST depression and T-wave inversion are expected secondary changes in RBBB (discordant to the terminal R')
• No clear primary ST elevation or acute ischemic changes are evident in the lateral leads

QTc Machine Reading

• The machine-reported QTc of 1040 ms is almost certainly artifactual — likely due to T-wave misidentification in the setting of RBBB morphology. Clinical QTc should be manually measured.

Summary

Clinical Correlation

• Isolated/incidental (normal variant, especially incomplete RBBB)
• Associated with: pulmonary embolism (acute RBBB — "S1Q3T3"), right heart strain, congenital heart disease (ASD), ischemia (RCA territory), cardiomyopathy, or myocarditis

• Clinical Wells score for PE
• D-dimer
• SpO₂, BP, HR
• Look for S1Q3T3 pattern (large S in lead I, Q wave + T inversion in lead III)

⚠️ This is an educational interpretation. All ECG findings must be confirmed by a qualified clinician in the context of the full clinical picture.

High Vitamin B12 (>2000 pg/mL) — Causes

1. Exogenous / Iatrogenic (Most Common, Benign)

First step: Always ask about supplements and recent injections before proceeding to workup.

2. Hepatic Disease 🟠 (Release from Stores)

Hepatic causes are the most common pathological cause in clinical practice.

3. Haematological Malignancies 🔴 (High Clinical Significance)

CML hallmark: Very high WBC + splenomegaly + B12 >2000 — elevated B12 was historically used as a diagnostic clue before the BCR-ABL era.

4. Solid Tumours 🔴

Elevated B12 in a patient with no known malignancy should prompt cancer screening, particularly if the CBC and liver function tests are abnormal.

5. Renal Disease

• Chronic kidney disease / renal failure — reduced renal clearance of TC-I–B12 complexes leads to accumulation

6. Macro-Vitamin B12 (Falsely Elevated) ⚠️

• Prevalence estimated ~18%
• Suspected when B12 is persistently elevated despite no clear cause
• Confirmed by PEG precipitation test — if B12 normalises after polyethylene glycol precipitation, true B12 is not elevated
• Clinically benign — no treatment needed

7. Other Causes

Pathophysiology: Why Does B12 Rise?

1. Increased TC-I (haptocorrin) production → myeloproliferative neoplasms, tumours, inflammation
2. Release from damaged hepatocytes → liver disease
3. Reduced clearance → renal failure
4. Exogenous loading → supplements/injections
5. Antibody interference → macro-B12

Suggested Workup for Unexplained B12 >2000

Step 1: Exclude supplements/injections (history)
Step 2: CBC with differential (↑WBC, blasts → haematology)
Step 3: Liver function tests + hepatitis screen (hepatic cause)
Step 4: Renal function (CKD)
Step 5: Tumour markers + imaging if abnormal (AFP for HCC, CT abdomen)
Step 6: Peripheral blood film + BCR-ABL if myeloproliferative neoplasm suspected
Step 7: If all negative → PEG precipitation to exclude macro-B12

⚠️ Key clinical pearl: An isolated B12 >2000 in a patient not on supplements carries a ~30–40% probability of underlying serious pathology (haematological malignancy, liver disease, or solid tumour) in published case series. Do not dismiss it without investigation.

B12 >2000 with All Other Tests Normal — Revised Differential

Most Likely ✅

Still Possible (Normal Labs Don't Fully Exclude)

Practical Next Steps

1. Confirm: Is the patient taking ANY B12 supplement, multivitamin, 
   energy drink, or fortified food? → Stop for 4–6 weeks and recheck B12

2. If still elevated after stopping supplements:
   → PEG precipitation test (rule out macro-B12)
   
3. If PEG precipitation normal (true elevation confirmed):
   → Abdominal ultrasound (liver, spleen)
   → Hepatitis B & C serology
   → Repeat CBC with differential in 4–6 weeks
   → JAK2 V617F mutation / BCR-ABL if WBC trending up

4. If all above negative and patient asymptomatic:
   → Monitor with repeat B12 + CBC at 3 and 6 months

Surviving Sepsis Campaign (SSC) 2026 Guidelines

129 statements total — 46 are brand new topics not covered in 2021. Panel of 69 experts from 23 countries.

1. Screening & Recognition

• Recommend a performance improvement programme (QI) for sepsis at all hospitals, including active sepsis screening for acutely ill high-risk patients
• Use of standardised screening tools + standard operating procedures
• New: Prehospital (pre-hospital/pre-ED) screening recommendations added for the first time

2. Antibiotics 💊 — "Fast AND Smart"

Key 2026 shift: Antimicrobial stewardship now a core integrated pillar of sepsis care — not an afterthought. Daily reassessment for narrowing/stopping.

3. Fluid Resuscitation 🩺

4. Vasopressors 💉

5. Perfusion Monitoring

6. Corticosteroids

• Hydrocortisone 200 mg/day IV (continuous infusion) for refractory septic shock (on vasopressors despite adequate resuscitation)
• Not routinely for all sepsis — only shock not responding to fluids + vasopressors
• No major change from 2021 here

7. Organ Support

8. Source Control

• Identify and control the source of infection as rapidly as possible
• Intervention (drainage, debridement, device removal) within 6–12 hours of identification where feasible
• Remove intravascular devices if they are the suspected source

9. New Domains in 2026 (Not in 2021)

• 🆕 Prehospital sepsis recognition and treatment
• 🆕 Post-sepsis recovery and survivorship — expanded focus on long-term outcomes, rehabilitation, psychological sequelae
• 🆕 Antifungal stewardship — explicit criteria to avoid unnecessary empiric antifungals
• 🆕 Fluid removal in post-resuscitation phase
• 🆕 Beta-blocker use (now against)
• 🆕 Resource-limited settings considered — 38% of panelists from LMICs

Quick Reference Summary Card

SEPSIS 2026 — Bedside Essentials

RECOGNIZE:  qSOFA / SOFA + clinical suspicion
CULTURES:   Blood cultures × 2 BEFORE antibiotics (don't delay Abx)
ANTIBIOTICS: Within 1h (shock) / 3h (sepsis). Broad → narrow. 5–7 days.
FLUIDS:     30 mL/kg balanced crystalloid × 3h. Then reassess. Don't auto-continue.
LACTATE:    Measure. Intermediate (2–4) also warrants resus. Trend-based monitoring.
VASO:       Norepinephrine first. MAP 65 (60–65 in elderly). Peripheral IV OK.
STEROIDS:   Hydrocortisone 200mg/day if refractory shock only.
SOURCE:     Control within 6–12h.
ICU:        Admit within 6h if indicated.
DE-ESCALATE: Daily review. Procalcitonin-guided stop. Shorter courses.

Fluid Removal in the Post-Resuscitation Phase — Explained

The Core Problem: Fluid Overload After Resuscitation

1. Capillary leak from systemic inflammation — fluid leaks into the interstitium rather than staying intravascular
2. Impaired renal excretion — sepsis-associated AKI reduces the kidney's ability to excrete the fluid load
3. Ongoing IV infusions — antibiotics, vasopressor infusions, nutrition all add volume

Why Fluid Overload Is Harmful

— Goldman-Cecil Medicine: "Excess fluid resuscitation is associated with increased mortality from septic shock."

The ROSE Framework — 4 Phases of Fluid Management

R — Resuscitation   (minutes)   → Give fluid to reverse shock
O — Optimisation    (hours)     → Fine-tune to maintain perfusion
S — Stabilisation   (hours–days) → Taper vasopressors, stop fluids
E — Evacuation      (days–weeks) → REMOVE accumulated excess fluid

What the SSC 2026 Recommends

Once the patient is haemodynamically stable and no longer in shock, actively remove accumulated fluid using diuretics. If diuresis is insufficient, consider ultrafiltration or extracorporeal fluid removal (e.g., CRRT).

How It's Done in Practice

Step 1 — Identify the right timing (stabilisation confirmed)

• Off vasopressors (or on low doses, weaning)
• Lactate normalising / normalised
• No clinical signs of shock
• Cumulative fluid balance significantly positive (often +5–10 L or more)

Step 2 — Active diuresis (first-line)

Step 3 — Extracorporeal fluid removal (if diuretics fail or AKI)

• CRRT (continuous renal replacement therapy) with ultrafiltration
• Intermittent haemodialysis with ultrafiltration prescription
• Net ultrafiltration rate typically 100–200 mL/hr, adjusted to haemodynamic tolerance

Monitoring Response to De-resuscitation

Current Evidence — Honest Appraisal

• No statistically significant mortality reduction with active de-resuscitation vs. usual care in RCTs (RR 1.12 [0.84–1.48])
• However, observational data consistently shows harm from persistent positive fluid balance
• Evidence limited by small RCT sample sizes, heterogeneous methods, and difficulty achieving actual fluid separation

Bottom line: The SSC 2026 recommendation is based on biological plausibility + observational evidence — the mortality benefit from RCTs is not yet conclusively proven, but the harms of persistent fluid overload are well established. Active de-resuscitation is considered best practice.

In Simple Terms

Think of it as a 2-stage process:

STAGE 1 (Emergency):   Fill the tank → give fluids to save life
STAGE 2 (Recovery):    Drain the excess → remove fluid to heal organs

Most teams are good at Stage 1.
SSC 2026 now mandates attention to Stage 2.

Patient Details

USG Findings — System-by-System

Radiologist's Impression (Summary)

1. 🟡 Grade II Fatty Liver
2. 🔴 Circumferential wall thickening of distal ileal loops (6–7 mm) — suggestive of enteritis
3. ✅ No other significant abnormality

Clinical Interpretation

Finding 1: Grade II Fatty Liver

• Obesity / overweight
• Type 2 diabetes mellitus
• Dyslipidaemia (high triglycerides)
• Metabolic syndrome
• Hypothyroidism

• Weight reduction (5–10% body weight loss improves histology)
• Dietary modification — reduce refined carbs, saturated fats
• Regular exercise
• Control of diabetes, lipids, thyroid
• Check: LFTs (ALT/AST), fasting glucose, HbA1c, lipid profile, TFT
• Avoid alcohol and hepatotoxic drugs
• No specific drug approved yet for NAFLD (pioglitazone/vitamin E in selected cases)

Finding 2: Distal Ileal Wall Thickening 6–7 mm ⚠️ (KEY FINDING)

Differential Diagnosis

⚠️ In India, intestinal tuberculosis must always be excluded before diagnosing Crohn's disease, as the treatment is opposite — steroids help Crohn's but worsen TB.

Recommended Investigations

BLOOD TESTS:
• CBC with differential (eosinophilia? anaemia?)
• ESR, CRP (inflammatory markers)
• LFTs, blood glucose, HbA1c, lipid profile (for fatty liver workup)
• Stool routine, culture, ova & parasites
• Stool for AFB (TB)
• Mantoux test / IGRA (QuantiFERON-TB) — exclude TB
• CA-125 (though no adnexal mass; precaution in post-hysterectomy female)

IMAGING:
• CT Abdomen with contrast — better characterisation of ileal wall thickening,
  mesenteric nodes, skip lesions
• CT Enterography (preferred) — dedicated small bowel protocol

ENDOSCOPY:
• Ileocolonoscopy with biopsy of terminal ileum — MOST IMPORTANT
  → Histology differentiates Crohn's vs TB vs lymphoma vs infectious
• Biopsy for AFB stain, culture, CBNAAT (TB-PCR)

Summary Table

⚠️ The distal ileal wall thickening is the clinically significant finding requiring urgent follow-up. In a 60-year-old Indian female, intestinal tuberculosis must be the first diagnosis to exclude before any other cause is entertained. Clinical correlation with symptoms (diarrhoea, weight loss, night sweats, fever) is essential.

FEVER — Complete Clinical Guide

Definition

• Normal body temperature: 36.1–37.2°C (97–99°F) oral
• Fever (pyrexia): ≥38°C (100.4°F)
• High-grade fever: >39°C (102.2°F)
• Hyperpyrexia: >41.5°C (106.7°F) — medical emergency
• FUO (Fever of Unknown Origin): Fever ≥38.3°C on ≥2 occasions, lasting >3 weeks, without diagnosis despite investigation — Harrison's Principles of Internal Medicine, 22nd Ed.

Pathophysiology

Infection / Tissue injury / Antigen
        ↓
Macrophages / Monocytes activated
        ↓
Release PYROGENS (IL-1, IL-6, TNF-α, IFN)
        ↓
Hypothalamus → PGE2 production (via COX-2)
        ↓
Temperature set-point RAISED
        ↓
Vasoconstriction + Shivering → Heat production → FEVER

Types / Patterns of Fever

Causes — By Category

🔴 Infections (Most Common Overall)

🟠 Non-Infectious Inflammatory (NIID)

🔵 Malignancy

🟡 Drug Fever

• Typically: fever without localising signs, relative bradycardia, rash in some
• Resolves within 72–96 hours of stopping the drug

⚪ Other Causes

Clinical Approach to Fever

Step 1 — History

• Duration, onset, pattern (continuous/intermittent?)
• Associated symptoms: rigors, chills, sweats, rash, cough, dysuria, diarrhoea, joint pains
• Travel history (malaria, typhoid, dengue — especially in India)
• Contact history, animal exposure, sexual history
• Drug history (drug fever?)
• Immunosuppression (HIV, diabetes, steroids, chemotherapy)

Step 2 — Examination

• Temperature — record properly; oral/axillary/rectal
• Pulse-temperature dissociation (relative bradycardia): Typhoid, Brucellosis, Legionella, drug fever
• Rash: Dengue (petechial), meningococcaemia (purpuric), typhoid (rose spots), viral exanthem
• Lymphadenopathy: EBV, lymphoma, HIV, TB
• Hepatosplenomegaly: Malaria, typhoid, EBV, kala-azar, lymphoma
• Jaundice: Hepatitis, malaria, leptospirosis, cholangitis
• Meningism: Bacterial meningitis
• Heart murmur: Infective endocarditis

Step 3 — Investigations

• CBC + differential (WBC count and type)
  - Neutrophilia → bacterial infection
  - Lymphocytosis → viral infection
  - Eosinophilia → parasites, drug reaction, fungal
  - Pancytopenia → malaria, dengue, kala-azar, typhoid
• ESR, CRP (inflammatory markers)
• Peripheral blood smear → malaria
• Blood cultures × 2 (before antibiotics)
• Urine R/E + culture
• LFTs, RFTs, blood glucose
• Chest X-ray

• NS1 antigen + dengue IgM/IgG → dengue
• Widal / Typhidot → typhoid
• Malaria RDT / thick & thin smear → malaria
• Scrub typhus IgM → if eschar present
• Leptospira IgM → flood exposure
• HIV 4th generation ELISA → HIV
• ANA, anti-dsDNA → SLE
• Blood culture in special media → brucellosis
• TST / IGRA → TB
• CT abdomen → abdominal abscess, lymphoma
• Echocardiography → infective endocarditis
• 18F-FDG PET/CT → FUO workup (high sensitivity for occult infection/malignancy)

Management

1. Antipyretics (Symptomatic)

⚠️ Do NOT routinely suppress every fever — fever is a host defence mechanism. Treat when causing discomfort, >39.5°C, or in high-risk patients (cardiac, CNS, elderly, infants).

2. Physical Cooling

• Tepid sponging (not ice-cold)
• Remove excess clothing
• Fan + cool environment
• IV fluids if dehydrated

3. Treat the Underlying Cause

• Infection → appropriate antibiotics/antivirals/antiparasitics
• Autoimmune → NSAIDs, steroids, DMARDs
• Malignancy → oncology referral
• Drug fever → stop offending drug

Red Flag Fever — Hospitalise / Urgent Referral

FUO — Causes by Category (Harrison's, 22nd Ed.)

In Asia and developing countries, infections (especially TB, enteric fever, malaria, kala-azar) account for a much higher proportion of FUO compared to Western Europe.

CT Brain — Non-Contrast Interpretation

Key Finding: ⚠️ LARGE HYPERDENSE (BRIGHT WHITE) LESION IN POSTERIOR FOSSA / CEREBELLUM

Finding 1 — LARGE CEREBELLAR / POSTERIOR FOSSA HYPERDENSITY 🔴

• Homogeneous hyperdensity — consistent with acute blood (density ~55–90 HU)
• The lesion appears large — possibly occupying a significant portion of the posterior fossa
• Mass effect on the 4th ventricle is likely
• Surrounding hypodense rim suggesting oedema
• Adjacent skull base and temporal bones visible — no obvious fracture lines visible on these cuts

Finding 2 — Ventricular System

• On the higher axial cuts, the lateral ventricles appear visible
• Possible early hydrocephalus if 4th ventricle is compressed
• Look for periventricular lucency as sign of transependymal CSF flow

Finding 3 — Cerebral Parenchyma (Supratentorial)

• Cortical sulci appear somewhat effaced in some cuts — possible diffuse cerebral oedema
• Basal ganglia and thalami appear relatively preserved
• No obvious supratentorial hyperdense lesions (no cortical haemorrhage visible)
• Grey-white matter differentiation appears relatively preserved supratentorially
• No obvious midline shift at supratentorial level

Finding 4 — Calvarium & Soft Tissues

• Scalp soft tissues appear normal
• No obvious depressed fracture visible
• Orbits and paranasal sinuses in lower cuts appear unremarkable

Radiological Impression

🔴 LARGE ACUTE HAEMORRHAGE IN THE POSTERIOR FOSSA / CEREBELLUM

Differential Diagnosis

Clinical Correlation — Cerebellar ICH Presentation

⚠️ URGENCY — This is a Neurosurgical Emergency

Immediate Management

EMERGENCY STEPS:
1. Urgent neurosurgery referral / ICU admission
2. Secure airway (GCS assessment — intubate if GCS ≤8)
3. IV access × 2, vitals monitoring
4. BP control: Target SBP 140–160 mmHg 
   (avoid aggressive lowering)
5. Reverse any anticoagulation immediately
   - Vitamin K + FFP / PCC if on warfarin
   - Andexanet alfa / idarucizumab if on NOAC
6. Mannitol 1g/kg IV — if signs of herniation
7. Head of bed 30°
8. Nil by mouth — aspiration risk
9. Seizure precautions
10. URGENT: CT Angiography (CTA) to rule out AVM/aneurysm

SURGICAL CONSIDERATION:
- Cerebellar ICH >3 cm OR with hydrocephalus/brainstem compression 
  → SURGICAL EVACUATION (posterior fossa craniotomy)
  → or External Ventricular Drain (EVD) for hydrocephalus
- Lesion <3 cm, GCS intact → conservative management possible

Risk Factors to Address (Likely in this 68M patient)

• Hypertension (most common cause — hypertensive ICH)
• Anticoagulant use (warfarin, NOACs, antiplatelets)
• Diabetes mellitus
• Amyloid angiopathy (less common in posterior fossa)

Summary

⚠️ This is a critical finding requiring immediate neurosurgical evaluation. Cerebellar ICH with posterior fossa compression can lead to rapid brainstem herniation and death if not managed urgently. Formal radiology report and neurosurgical assessment are mandatory.